RRX vs TECH · P/E 52, rev $6.25B vs P/E 65, rev $1.22B
Regal Beloit Corporation (RRX) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Regal Beloit Corporation (RRX) is a specialty industrial machinery company listed on NYSE.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported RRX revenue for 2023-12-31 was $6.25B. Net income was -$54.3M. Revenue was up 19.8% from 2022-12-31 to 2023-12-31. RRX currently screens at market cap $14.92B and trailing P/E 52.2.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
RRX currently screens at market cap $14.92B and trailing P/E 52.2. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the RRX and TECH stock pages for the full models.
Not investment advice.